skip-to-main

Spikevax XBB.1.5

0.1 mg/mL formulation

Spikevax XBB.1.5 is indicated for active immunisation to prevent COVID-19 disease caused by SARS- CoV-2 in individuals 6 months of age and older.

xbb.1.5 carton

Patient Information Leaflet

Summary of Product Characteristics

Tools

Temperature Excursion Tool

See what to do with vials of the Moderna COVID-19 Vaccine that may have experienced a temperature excursion prior to administering.

Report Adverse Events

You can report any adverse events to Moderna via the Adverse Event Intake Portal or by calling 1-800-622-4937.

Contact Moderna

    © 2024 Moderna, Inc.

    SG-COV-2100003 11/2023